B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10

Thrombosis and Haemostasis

Volumn 114, Issue 4, 2015, Pages 835-847

  Strom, Asa C ^a   Cross, Amanda J ^a   Cole, Jennifer E ^a   Blair, Paul A ^b   Leib, Christoph ^a   Goddard, Michael E ^a   Rosser, Elizabeth C ^b   Park, Inhye ^a   Nilsson, Anna Hultgårdh ^c   Nilsson, Jan ^d   Mauri, Claudia ^b   Monaco, Claudia ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LUND UNIVERSITY   (Sweden)

^d MALMÖ UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; B regulatory cells; Immunity; Interleukins; Vascular disease

Indexed keywords

CD23 ANTIGEN; CD24 ANTIGEN; CD40 LIGAND; CD68 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSCRIPTION FACTOR FOXP3; APOLIPOPROTEIN E; CD24A PROTEIN, MOUSE; CD40 ANTIGEN; IL10 PROTEIN, MOUSE; IMMUNOGLOBULIN E RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; ATHEROSCLEROSIS; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART PROTECTION; HYPERCHOLESTEROLEMIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LYMPHOCYTE SUBPOPULATION; MACROPHAGE MIGRATION; MORPHOMETRICS; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; ADAPTIVE IMMUNITY; ANIMAL; B LYMPHOCYTE; C57BL MOUSE; CAROTID ARTERY; CAROTID ARTERY DISEASES; CAROTID ARTERY INJURIES; CELL CULTURE; CELL PROLIFERATION; COMPLICATION; DEFICIENCY; DISEASE MODEL; GENETICS; GENOTYPE; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHENOTYPE; PROTECTION; SIGNAL TRANSDUCTION; TIME FACTOR; TRANSPLANTATION;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD24; ANTIGENS, CD40; APOLIPOPROTEINS E; B-LYMPHOCYTE SUBSETS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID ARTERY INJURIES; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; HYPERCHOLESTEROLEMIA; INTERLEUKIN-10; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOINTIMA; PHENOTYPE; PROTECTIVE FACTORS; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 84943192416     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-12-1084     Document Type: Article

References (42)

1. Buono C, Binder C, Stavrakis G, et al. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci USA 2005; 102: 1596-1601.
2. Ait-Oufella H, Salomon BL, Potteaux S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006; 12: 178-180.
3. Ait-Oufella H, Herbin O, Bouaziz JD, et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010; 207: 1579-1587.
4. Kyaw T, Tay C, Khan A, et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010; 185: 4410-4419.
5. Sasaki Y, Casola S, Kutok JL, et al. TNF family member B cell-activating factor (BAFF) receptor-dependent and-independent roles for BAFF in B cell physiology. J Immunol 2004; 173: 2245-2252.
6. Kyaw T, Tay C, Hosseini H, et al. Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PloS one 2012; 7: e29371.
7. Sage AP, Tsiantoulas D, Baker L, et al. BAFF receptor deficiency reduces the development of atherosclerosis in mice--brief report. Arterioscler Thromb Vasc Biol 2012; 32: 1573-1576.
8. Kyaw T, Cui P, Tay C, et al. BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice. PloS one 2013; 8: e60430.
9. Major A, Fazio S, Linton M. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002; 22: 1892-1898.
10. Caligiuri G, Nicoletti A, Poirier B, et al. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002; 109: 745-753.
11. Doran AC, Lipinski MJ, Oldham SN, et al. B-cell aortic homing and atheroprotection depend on Id3. Circ Res 2012; 110: e1-12.
12. Gjurich BN, Taghavie-Moghadam PL, Ley K, et al. L-selectin deficiency decreases aortic B1a and Breg subsets and promotes atherosclerosis. Thromb Haemost 2014; 112: 803-811.
13. Dimayuga P, Cercek B, Oguchi S, et al. Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice. Arterioscler Thromb Vasc Biol 2002; 22: 644-649.
14. Hayakawa K, Hardy RR, Herzenberg LA, et al. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med 1985; 161: 1554-1568.
15. Kyaw T, Tay C, Krishnamurthi S, et al. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 2011; 109: 830-840.
16. Shaw PX, Hörkkö S, Chang MK, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000; 105: 1731-1740.
17. Lewis MJ, Malik TH, Ehrenstein MR, et al. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2009; 120: 417-426.
18. Mauri C, Gray D, Mushtaq N, et al. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003; 197: 489-501.
19. Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007; 178: 7868-7878.
20. Matsushita T, Yanaba K, Bouaziz J-D, et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008; 118: 3420-3430.
21. Rosser EC, Oleinika K, Tonon S, et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production. Nat Med 2014; 20: 1334-1339.
22. Chyu KY, Dimayuga P, Zhu J, et al. Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res 1999; 85: 1192-1198.
23. Asseman C, Mauze S, Leach MW, et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995-1004.
24. Cole JE, Navin TJ, Cross AJ, et al. Unexpected protective role for Toll-like receptor 3 in the arterial wall. Proc Natl Acad Sci USA 2011; 108: 2372-2377.
25. Meyer-Bahlburg A, Andrews SF, Yu KO, et al. Characterisation of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J Exp Med 2008; 205: 155-168.
26. Blair PA, Chavez-Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 2009; 182: 3492-3502.
27. Angeli V, Llodrá J, Rong JX, et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilisation. Immunity 2004; 21: 561-574.
28. Binder CJ, Hartvigsen K, Chang M-K, et al. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 2004; 114: 427-437.
29. Mizoguchi A, Mizoguchi E, Takedatsu H, et al. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16: 219-230.
30. Srivastava B, Quinn WJ, 3rd, Hazard K, et al. Characterisation of marginal zone B cell precursors. J Exp Med 2005; 202: 1225-1234.
31. Grammer AC, Bergman MC, Miura Y, et al. The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol 1995; 154: 4996-5010.
32. Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999; 85: e17-24.
33. Caligiuri G, Rudling M, Ollivier V, et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 2003; 9: 10-17.
34. Zimmerman MA, Reznikov LL, Raeburn CD, et al. Interleukin-10 attenuates the response to vascular injury. J Surg Res 2004; 121: 206-213.
35. Mazighi M. IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo. Am J Physiol Heart Circ Physiol 2004; 287: H866-H871.
36. Eefting D, Schepers A, De Vries MR, et al. The effect of interleukin-10 knockout and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice. Atherosclerosis 2007; 193: 335-342.
37. Mauri C, Bosma A. Immune Regulatory Function of B Cells. Ann Rev Immunol 2012;30:null.
38. Mallat Z, Gojova A, Brun V, et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003; 108: 1232-1237.
39. Lipinski MJ, Perry HM, Doran AC, et al. Comment on „Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis”. J Immunol 2011; 186: 4; author reply 6.
40. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 2009; 9: 767-777.
41. Yoshizaki A, Miyagaki T, DiLillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012; 491: 264-268.
42. Blair PA, Noreña LY, Flores-Borja F, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010; 32: 129-140.